WOLVERINE ASSET MANAGEMENT LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 147 filers reported holding NEKTAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2020$424,000
+731.4%
25,587
+1046.4%
0.00%
+300.0%
Q2 2020$51,000
-23.9%
2,232
-50.4%
0.00%0.0%
Q4 2014$67,000
+15.5%
4,5010.0%0.00%0.0%
Q3 2014$58,0004,501
+37408.3%
0.00%
Q2 2014$012
+1100.0%
0.00%
Q1 2014$0
-100.0%
1
-98.1%
0.00%
Q3 2013$3,000
-97.4%
52
-99.4%
0.00%
-100.0%
Q2 2013$116,0008,8990.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2014
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders